These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4058271)

  • 21. Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats.
    Hiranuma S; Ito K; Noda Y; Ozasa H; Koike Y; Horikawa S
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2167-72. PubMed ID: 18031376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine.
    Mikati MA; Szabo GK; Pylilo RJ; LeDuc BW; Browne TR; Greenblatt DJ
    J Chromatogr; 1988 Dec; 433():305-11. PubMed ID: 3235560
    [No Abstract]   [Full Text] [Related]  

  • 23. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
    Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
    Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M; Krom DP; Breimer DD
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
    Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
    Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C.
    Ali HA; el-Yazigi A; Sieck JO; Ali MA; Raines DA; Saour J; Ernst P; Khan B; Døssing M
    J Hepatol; 1995 Jan; 22(1):17-21. PubMed ID: 7751582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography.
    Inaba T; Fischer NE
    Can J Physiol Pharmacol; 1980 Jan; 58(1):17-21. PubMed ID: 7378903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edaravone reduces ischemia-reperfusion injury mediators in rat liver.
    Taniguchi M; Uchinami M; Doi K; Yoshida M; Sasaki H; Tamagawa K; Horiuchi T; Tanaka K
    J Surg Res; 2007 Jan; 137(1):69-74. PubMed ID: 17064733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between antipyrine metabolism and acetylation phenotype in health and chronic liver diseases.
    el-Yazigi A; Raines DA; Wahab FA; Sieck JO; Ernst P; Ali H; Dossing M
    J Clin Pharmacol; 1995 Jun; 35(6):615-21. PubMed ID: 7665722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
    van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of varying percentages of haemodilution with fluosol-DA or normal saline on antipyrine metabolism in the rat.
    Shrewsbury RP; Oliver SR; Anderson WT; Lewis LM; White LG
    J Pharm Pharmacol; 1988 Jun; 40(6):392-8. PubMed ID: 2901469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of alaproclate on antipyrine metabolite formation in man.
    Teunissen MW; Wahlén A; Vinnars E; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(4):447-52. PubMed ID: 6519152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat.
    Witkamp RF; Nijmeijer SM; Kolker HJ; Noordhoek J; van Miert AS
    J Vet Pharmacol Ther; 1993 Jun; 16(2):164-73. PubMed ID: 8345566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ; Purba HS; Park BK; Ward SA; Orme ML
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.
    Gachályi B; Vas A; Csillag K; Nagy B; Kocsis F; Káldor A
    Eur J Clin Pharmacol; 1987; 31(5):613-5. PubMed ID: 3830247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.